Real-World Safety Of Ruxolitinib In Patients With Intermediate Or High Risk Of Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis Or Post-Essential Thrombocythemia Myelofibrosis In China
Ruxolitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Real-World Safety Of Ruxolitinib In Patients With Intermediate Or High Risk Of Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis Or Post-Essential Thrombocythemia Myelofibrosis In China ### Output: Ruxolitinib